By Counterforce Health Team in Stelara (ustekinumab) —

Renewing Stelara (Ustekinumab) Approval with Blue Cross Blue Shield of Texas: 2025 Requirements & Timeline

Answer Box: Renewing Stelara with Blue Cross Blue Shield of Texas

Blue Cross Blue Shield of Texas requires annual prior authorization renewal for Stelara (ustekinumab) 30-60 days before expiration. You'll need updated clinical documentation showing continued medical necessity and treatment response. Start early: BCBSTX makes decisions within 3 business days for standard requests, 24 hours for urgent cases. If denied, you can appeal within 180 days and request external review through Texas Department of Insurance.

First step today: Contact your prescriber to schedule renewal documentation review and confirm your current authorization expiration date.

Table of Contents

  1. When to Start Your Renewal
  2. Required Documentation Update
  3. Renewal Submission Process
  4. Decision Timeline & What to Expect
  5. If Your Coverage Lapses
  6. Annual Changes to Watch
  7. Personal Renewal Tracker
  8. Appeals Process for Texas
  9. FAQ

When to Start Your Renewal

Renewal Timing Windows

Start 30-60 days early. Blue Cross Blue Shield of Texas requires annual reauthorization for Stelara, and early submission prevents coverage gaps that could interrupt your treatment.

Signs you should start immediately:

  • Your current authorization expires within 60 days
  • You've had dose changes or new lab results
  • Your diagnosis has been updated or expanded
  • You've experienced any significant side effects
Tip: Set a calendar reminder 90 days before your expiration date to begin gathering documents.

Coverage Continuation Rules

BCBSTX typically provides a grace period for renewals submitted before expiration, but this isn't guaranteed. Late submissions may result in coverage gaps requiring bridge therapy through Janssen's patient assistance programs.

Required Documentation Update

Evidence of Continued Medical Necessity

Your prescriber must document that you still meet BCBSTX's clinical criteria for Stelara. This includes:

For Psoriasis/Psoriatic Arthritis:

  • Current disease severity assessment
  • Body Surface Area (BSA) or Psoriasis Area and Severity Index (PASI) scores
  • Joint involvement documentation (for psoriatic arthritis)
  • Photos or clinical notes describing current lesions

For Crohn's Disease/Ulcerative Colitis:

  • Recent colonoscopy or imaging results
  • Disease activity indices (CDAI, Mayo Score)
  • Biomarker levels (CRP, fecal calprotectin)
  • Symptom frequency and severity logs

Treatment Response Documentation

Clinical benefit evidence is crucial for renewal approval. Your doctor should include:

  • Objective improvement measures since starting Stelara
  • Comparison to pre-treatment baseline
  • Quality of life improvements
  • Absence of serious adverse effects

Lab monitoring results may include therapeutic drug monitoring if loss of response is suspected:

  • Trough ustekinumab levels (drawn immediately before next dose)
  • Anti-ustekinumab antibody testing
  • Standard safety labs (CBC, liver function, TB screening)
Note: If you take high-dose biotin supplements, discontinue them 72 hours before blood draws to avoid test interference.

Updated Clinical Information

Submit recent documentation including:

  • Chart notes from the last 12 months
  • Any emergency department visits or hospitalizations
  • Medication adherence records
  • Concurrent therapy changes

Renewal Submission Process

Submission Methods

BCBSTX accepts renewal requests through multiple channels:

  1. Availity Authorization & Referrals portal (preferred for providers)
  2. Blue Approvr system
  3. Phone submission using the prior authorization number on your member ID card

Required Forms and Documentation

Your prescriber must submit:

  • Completed prior authorization form
  • Letter of medical necessity
  • Recent clinical notes (last 6-12 months)
  • Laboratory results and imaging
  • Previous treatment history and outcomes

For specialty pharmacy coordination: Many patients receive Stelara through specialty pharmacies that can assist with renewal documentation collection and submission.

Decision Timeline & What to Expect

Standard Processing Times

BCBSTX decision timelines:

  • Standard requests: Within 3 business days
  • Urgent requests: Within 24 hours
  • Appeals: 7 days for standard, 1 business day for expedited

Expedited Reviews

Request expedited processing if:

  • Delay would jeopardize your health
  • You're at risk of hospitalization
  • Current symptoms are worsening rapidly

Mark requests clearly as "urgent" and include clinical justification for expedited review.

If Your Coverage Lapses

Bridge Therapy Options

Janssen Link Program provides temporary Stelara supply if:

  • Insurance coverage is delayed more than 5 business days
  • Your renewal is denied but appeals are pending
  • You're transitioning between insurance plans

Eligibility requirements:

  • Completed Patient Authorization form
  • Active efforts by your prescriber to obtain coverage
  • Not enrolled in Medicare, Medicaid, or government programs

Contact: Janssen CarePath at 877-227-3728 for immediate assistance.

Emergency Prescription Options

If you need Stelara urgently while awaiting renewal:

  • Request a temporary supply from your specialty pharmacy
  • Ask your prescriber about dose timing adjustments
  • Consider expedited appeal if medically appropriate

Counterforce Health helps patients and clinicians turn insurance denials into targeted, evidence-backed appeals by analyzing denial letters, plan policies, and clinical notes to draft point-by-point rebuttals aligned with your plan's specific requirements.

Annual Changes to Watch

2025 Formulary Updates

Key changes for Stelara coverage:

Biosimilar Transitions

Some plans are transitioning to biosimilar alternatives. If your plan switches coverage:

  • Your prescriber can request a medical exception
  • Existing prior authorizations may transfer to biosimilars
  • Appeal if medically necessary to continue brand Stelara

Plan Design Changes

Review your annual benefits summary for:

  • Copay or coinsurance changes
  • Specialty tier adjustments
  • New step therapy requirements
  • Provider network modifications

Personal Renewal Tracker

90 Days Before Expiration

  • Set renewal reminder
  • Review current authorization details
  • Schedule appointment with prescriber

60 Days Before Expiration

  • Gather recent lab results
  • Collect clinical documentation
  • Schedule any needed assessments

30 Days Before Expiration

  • Submit renewal request
  • Confirm receipt with BCBSTX
  • Follow up with specialty pharmacy

After Submission

  • Track decision timeline
  • Prepare appeal documents if needed
  • Coordinate with Janssen CarePath if delays occur

Appeals Process for Texas

Internal Appeals

If your renewal is denied, you have 180 days to file an internal appeal with BCBSTX.

Required documentation:

  • Copy of denial letter
  • Updated letter of medical necessity
  • Additional clinical evidence
  • Treatment response documentation

External Review

After internal appeal denial, you can request independent external review through the Texas Department of Insurance.

Timeline: Up to 4 months from final internal denial Cost: Free (insurer pays IRO fees) Decision: Binding on BCBSTX

Expedited external review available concurrently with expedited internal appeals if delay threatens your health.

FAQ

How long does BCBS Texas prior authorization take for Stelara renewals? Standard renewals receive decisions within 3 business days. Urgent requests are decided within 24 hours.

What if my Stelara renewal is denied? You can appeal within 180 days. File an internal appeal first, then request external review through Texas Department of Insurance if needed.

Do I need new lab work for my renewal? Recent clinical documentation is required, including any relevant lab results from the past 6-12 months showing treatment response and safety monitoring.

Can I get expedited renewal if I'm running out of medication? Yes, if delay would jeopardize your health. Mark your request as urgent and provide clinical justification.

What happens if my plan switches to a Stelara biosimilar? Your prescriber can request a medical exception to continue brand Stelara if clinically necessary. Existing prior authorizations may transfer to biosimilars.

Are there patient assistance programs if my renewal is delayed? The Janssen Link Program provides temporary Stelara supply for eligible patients with insurance delays or denials.

When navigating complex insurance requirements and appeals, Counterforce Health provides specialized support by analyzing your specific denial reasons and crafting targeted appeals with the clinical evidence and procedural requirements your plan demands.

Sources & Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Insurance policies and coverage criteria can change. Always verify current requirements with your insurance plan and consult your healthcare provider for medical decisions. For assistance with insurance appeals in Texas, contact the Texas Department of Insurance at 1-800-252-3439.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.